Insmed Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IM8N.SG | 0A3M.IL | ROIV | 1952.HK | 6IB.F | TRVI | |
|---|---|---|---|---|---|---|
| Market cap | 21.56B | 25.02B | 27.61B | 9.83B | 17.33B | 1.99B |
| P/E (TTM) | — | 5.1 | — | — | 124.2 | — |
| Forward P/E | — | 5.0 | -27.5 | 20.4 | — | -24.2 |
| Price/book | 33.3 | 1.1 | 6.5 | 1.3 | 6.2 | 6.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −38.88% | −13.17% | +85.85% | −44.53% | −1.76% | +27.02% |
| Today | +1.13% | +2.19% | +6.08% | +5.06% | +3.73% | +0.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All IM8N.SG news ›Analyzing Insmed (NASDAQ:INSM) and Moderna (NASDAQ:MRNA)
Posted by Michael Walen on Nov 2nd, 2026 Moderna (NASDAQ:MRNA – Get Free Report) and Insmed (NASDAQ:INSM – Get Free Report) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses…
Insmed Incorporated (INSM) Q3 2026 Earnings Call Transcript
Insmed Incorporated (INSM) Q3 2026 Earnings Call October 29, 2026 8:00 AM EDT William Lewis - President, CEO & ChairmanSara BonsteinMartina Flammer - Chief Medical Officer Please refer to Insmed's most recent filings with the Securities…
Why Did Insmed Stock Jump?
Insmed (INSM) shares rose 15.1% on Thursday, October 29, 2026, while the S&P 500 fell 0.3%. The gain accompanied the release of Insmed’s third-quarter 2026 results. Revenue beat analysts’ estimates, but the loss per share was wider than…
Insmed (INSM) Gets a Buy from Roth MKM
Roth MKM analyst Adam Walsh reiterated a Buy rating on Insmed today and set a price target of $198.00. According to TipRanks, Walsh is an analyst with an average return of -0.3% and a 38.57% success rate. Walsh covers the Healthcare…
Insmed surges on Q3 revenue beats, revenue guidance range raise
Insmed stock jumps after Q3 revenue beat and higher 2025 guidance for Brinsupri and Arikayce. - Insmed (INSM) is up ~13% in Thursday trading after reporting Q3 financial results that beat on revenue and raising full-year revenue guidance…
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update
Happy Halloween! Plenty of spooky sunshine with light winds. A bit cooler than recent days but a dry treat. It's the last 6pm sunset of the year as we fall back the clocks overnight. . Partly cloudy skies for Halloween night; evening temps…
Insmed: Q3 Earnings Snapshot
BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $100.3 million in its third quarter. The Bridgewater, New Jersey-based company said it had a loss of 46 cents per share. The results missed…
Insmed Incorporated 2026 Q3 - Results - Earnings Call Presentation
2026-10-29. The following slide deck was published by Insmed Incorporated in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Insmed Incorporated in conjunction with their 2026 Q3 earnings call.
Citizens Financial Group Inc. RI Makes New Investment in Insmed, Inc. $INSM
Posted by Defense World Staff on Oct 28th, 2026 Citizens Financial Group Inc. RI acquired a new position in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) during the third quarter, according to its most recent filing with the…
Insmed names former Sanofi and Novartis CEO Hudson and biopharma exec Koppikar to board
Biopharmaceutical company Insmed Inc. announced Oct. 20 the appointment of ex-Sanofi and Novartis CEO Paul Hudson and Verily Health Chief Financial Officer Utpal Koppikar as independent members of its board of directors, effective…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com6
- prnewswire.com3
- seekingalpha.com3
- defenseworld.net1
- mmm-online.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 25 articles, not a forecast.